112 related articles for article (PubMed ID: 37790851)
1. STARD12/14 are diagnostic and prognostic biomarkers of lung adenocarcinoma associated with epigenetic regulation, immune infiltration and ferroptosis.
Zhang WD; Hu DM; Shi ZE; Wang QX; Zhang MY; Liu JY; Ji XL; Qu YQ
Int J Med Sci; 2023; 20(11):1427-1447. PubMed ID: 37790851
[No Abstract] [Full Text] [Related]
2. SPC25 as a novel therapeutic and prognostic biomarker and its association with glycolysis, ferroptosis and ceRNA in lung adenocarcinoma.
Liu XS; Zhang Y; Ming X; Hu J; Chen XL; Wang YL; Zhang YH; Gao Y; Pei ZJ
Aging (Albany NY); 2024 Jan; 16(1):779-798. PubMed ID: 38217547
[TBL] [Abstract][Full Text] [Related]
3. New molecular insights into ferroptosis in lung adenocarcinoma progression and pharmacological compounds for targeted therapy.
Tian W; Wan X; Tian L; Wu Y; Cui X; Yi J
J Gene Med; 2024 Jan; 26(1):e3579. PubMed ID: 37581210
[TBL] [Abstract][Full Text] [Related]
4. A ferroptosis-related LncRNAs signature for predicting prognoses and screening potential therapeutic drugs in patients with lung adenocarcinoma: A retrospective study.
Dong J; Tao T; Yu J; Shan H; Liu Z; Zheng G; Li Z; Situ W; Zhu X; Li Z
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1925. PubMed ID: 38043920
[TBL] [Abstract][Full Text] [Related]
5. Implications of GCLC in prognosis and immunity of lung adenocarcinoma and multi-omics regulation mechanisms.
Huang Z; Liang F; Wu J; Huang Z; Li Y; Huang X; Liu Z
BMC Pulm Med; 2024 May; 24(1):239. PubMed ID: 38750474
[TBL] [Abstract][Full Text] [Related]
6. Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker.
Yang W; Liu Z; Liu T
Cell Signal; 2024 May; 117():111107. PubMed ID: 38369265
[TBL] [Abstract][Full Text] [Related]
7. Role of ALOX5 in non-small cell lung cancer: A potential therapeutic target associated with immune cell infiltration.
Zhao Q; Sun Z; Pan Y; Jing Q; Li W; Wang C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):311-322. PubMed ID: 37164914
[TBL] [Abstract][Full Text] [Related]
8. NME6 as a potential biomarker and therapeutic target involved in immune infiltration for lung adenocarcinoma.
Luo L; Li Y; Zhang L; Yang L
Technol Health Care; 2024 Feb; ():. PubMed ID: 38517815
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of TNFSF11 reduces GPX4 levels and increases sensitivity to ferroptosis inducers in lung adenocarcinoma.
Li Z; Lu W; Yin F; Zeng P; Li H; Huang A
J Transl Med; 2024 Apr; 22(1):340. PubMed ID: 38594779
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil infiltration associated genes on the prognosis and tumor immune microenvironment of lung adenocarcinoma.
Liu R; Zhu G; Sun Y; Li M; Hu Z; Cao P; Li X; Song Z; Chen J
Front Immunol; 2023; 14():1304529. PubMed ID: 38204755
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of POC1A in lung adenocarcinoma promotes tumour progression and predicts poor prognosis.
Li ZH; Li JY; Wu ZT; Zhu YJ; Zhuo T; Nong JS; Qian J; Peng HJ; Dai L; Wang YY; Chen MW; Zeng XC
J Cell Mol Med; 2024 Mar; 28(6):e18135. PubMed ID: 38429900
[TBL] [Abstract][Full Text] [Related]
12. Cancer testis antigen MAGEA3 in serum and serum-derived exosomes serves as a promising biomarker in lung adenocarcinoma.
Gan Y; Kang Y; Zhong R; You J; Chen J; Li L; Chen J; Chen L
Sci Rep; 2024 Mar; 14(1):7573. PubMed ID: 38555374
[TBL] [Abstract][Full Text] [Related]
13. FSTL3 is associated with prognosis and immune cell infiltration in lung adenocarcinoma.
Meng X; Zhao X; Zhou B; Song W; Liang Y; Liang M; Du M; Shi J; Gao Y
J Cancer Res Clin Oncol; 2024 Jan; 150(1):17. PubMed ID: 38240936
[TBL] [Abstract][Full Text] [Related]
14.
Chen P; Quan Z; Song X; Gao Z; Yuan K
Front Oncol; 2022; 12():1005962. PubMed ID: 36300089
[TBL] [Abstract][Full Text] [Related]
15. Super-enhancer mediated upregulation of MYEOV suppresses ferroptosis in lung adenocarcinoma.
Luo S; Luo Y; Wang Z; Yin H; Wu Q; Du X; Xie X
Cancer Lett; 2024 May; 589():216811. PubMed ID: 38490328
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Diagnostic and Prognostic Predictive Values of Ferroptosis- Related Markers in Lung Adenocarcinoma.
Mao G; Xu W; Jamil M; Zhang W; Jiao N; Liu Y
Curr Pharm Biotechnol; 2024 Mar; ():. PubMed ID: 38523537
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis patterns modulate immunocyte communication in tumor microenvironments: clinical value and therapeutic guidance of lung adenocarcinoma.
Wang P; Wang Y; Wang Y
Funct Integr Genomics; 2023 May; 23(2):181. PubMed ID: 37231311
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics and experimental approach identify lipocalin 2 as a diagnostic and prognostic indicator for lung adenocarcinoma.
Li A; Zhang K; Zhou J; Li M; Fan M; Gao H; Ma R; Gao L; Chen M
Int J Biol Macromol; 2024 Jun; 272(Pt 2):132797. PubMed ID: 38848833
[TBL] [Abstract][Full Text] [Related]
19. DEP domain containing 1 as a biomarker for poor prognosis in lung adenocarcinoma.
Li C; Zhu X
Heliyon; 2024 May; 10(9):e30642. PubMed ID: 38765113
[TBL] [Abstract][Full Text] [Related]
20. PERP May Affect the Prognosis of Lung Adenocarcinoma by Inhibiting Apoptosis.
Liu Z; Han S; Luo Y; Zhao Z; Ni L; Chai L; Tang H
Cancer Manag Res; 2024; 16():199-214. PubMed ID: 38525370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
